Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

473 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The insulin-like growth factor 1 receptor in cancer: old focus, new future.
Hartog H, Wesseling J, Boezen HM, van der Graaf WT. Hartog H, et al. Among authors: van der graaf wt. Eur J Cancer. 2007 Sep;43(13):1895-904. doi: 10.1016/j.ejca.2007.05.021. Epub 2007 Jul 10. Eur J Cancer. 2007. PMID: 17624760 Review.
In vitro and in vivo modulation of multi-drug resistance with amiodarone.
van der Graaf WT, de Vries EG, Uges DR, Nanninga AG, Meijer C, Vellenga E, Mulder PO, Mulder NH. van der Graaf WT, et al. Int J Cancer. 1991 Jun 19;48(4):616-22. doi: 10.1002/ijc.2910480422. Int J Cancer. 1991. PMID: 1646180
Mitoxantrone: bluebeard for malignancies.
van der Graaf WT, de Vries EG. van der Graaf WT, et al. Anticancer Drugs. 1990 Dec;1(2):109-25. Anticancer Drugs. 1990. PMID: 2151849
Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.
Mulder NH, van der Graaf WT, Willemse PH, Koops HS, de Vries EG, Sleijfer DT. Mulder NH, et al. Among authors: van der graaf wt. Br J Cancer. 1994 Oct;70(4):681-3. doi: 10.1038/bjc.1994.372. Br J Cancer. 1994. PMID: 7522510 Free PMC article. Clinical Trial.
Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.
Schröder CP, van der Graaf WT, Kema IP, Groenewegen A, Sleijfer DT, de Vries EG. Schröder CP, et al. Among authors: van der graaf wt. Cancer Chemother Pharmacol. 1995;36(6):477-82. doi: 10.1007/BF00685797. Cancer Chemother Pharmacol. 1995. PMID: 7554039
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.
de Jong RS, Willemse PH, Boonstra H, de Vries EG, van der Graaf WT, Sleijfer DT, van der Zee AG, Mulder NH. de Jong RS, et al. Among authors: van der graaf wt, van der zee ag. Eur J Cancer. 1995;31A(5):709-13. doi: 10.1016/0959-8049(94)00516-8. Eur J Cancer. 1995. PMID: 7640042 Clinical Trial.
Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer.
Mulder NH, Dolsma WV, Mulder PO, De Vries EG, Willemse PH, Sleijfer DT, Hospers GA, Van der Graaf WT. Mulder NH, et al. Among authors: van der graaf wt. Anticancer Res. 1995 Jul-Aug;15(4):1565-8. Anticancer Res. 1995. PMID: 7654046 Clinical Trial.
In vitro and in vivo studies on the action of BW502U83, an arylmethylaminopropanediol.
van der Graaf WT, Zijlstra JG, de Vries EG, Nethersell AB, Mulder NH. van der Graaf WT, et al. Anticancer Drugs. 1995 Feb;6(1):34-9. doi: 10.1097/00001813-199502000-00003. Anticancer Drugs. 1995. PMID: 7756681 Clinical Trial.
Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.
Gietema JA, Veldhuis GJ, Guchelaar HJ, Willemse PH, Uges DR, Cats A, Boonstra H, van der Graaf WT, Sleijfer DT, de Vries EG, et al. Gietema JA, et al. Among authors: van der graaf wt. Br J Cancer. 1995 Jun;71(6):1302-7. doi: 10.1038/bjc.1995.252. Br J Cancer. 1995. PMID: 7779728 Free PMC article. Clinical Trial.
The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts.
van der Graaf WT, Mulder NH, Meijer C, de Vries EG. van der Graaf WT, et al. Cancer Chemother Pharmacol. 1995;35(4):345-8. doi: 10.1007/BF00689457. Cancer Chemother Pharmacol. 1995. PMID: 7828280
473 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback